The Networked Pill From Proteus Biomedical
Share
Michael Chorost published an article in MIT Technology Review about a networked pill from a company called Proteus Biomedical. The pill, called Raisin, releases a sand grain sized microchip into the body in addition to releasing the prescription.
This microchip is activated on contact with water in the body and sends electrical currents through the body as its form of communication. That's right...no wireless signal, just electrical currents that are picked up by a receiver that is patched onto the body or as a subcutaneous insert.
Be Part of the Future
Sign up to receive top stories about groundbreaking technologies and visionary thinkers from SingularityHub.
There are two major advantages that this networked pill will offer. First, it will allow doctors to monitor whether patients are actually taking the medication in the quantity and frequency that they are supposed to by checking the logs from the receiver. Second, doctors can monitor physiological parameters such as heart rate before, during, and after taking the medication to better understand the impact of the medication on the patient. Some quotes from the article:
"...the dosages of drugs used for heart failure are derived from large
clinical trials and may not meet a particular patient's needs. "Imagine
a situation where drug ingestion is tracked, and heart pressure before,
immediately after, and later are known," says Saxon. "That represents
real, individualized, tailored drug therapy."
Related Articles
Virtual Biotech Company Puts 37,000 AI Agents to Work on Drug Discovery
The Next Frontier Is Not Artificial Intelligence—It’s Artificial Societies
Single CAR T Injection Eases Multiple Sclerosis Symptoms in Small Trial
Virtual Biotech Company Puts 37,000 AI Agents to Work on Drug Discovery
The Next Frontier Is Not Artificial Intelligence—It’s Artificial Societies
Single CAR T Injection Eases Multiple Sclerosis Symptoms in Small Trial
What we’re reading